NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Researchers publish new studies and findings in the area of breast cancer



April 28th, 2005

New findings from Canada, the United States and Spain describe advances in breast cancer.

Study 1: Reduced expression of the PTEN gene is predictive of relapse in breast cancer patients treated with tamoxifen, researchers have found.

"Tamoxifen treatment substantially improves the 10-year survival of women with estrogen-receptor (ER)-alpha positive tumors. However, approximately one-third of all breast cancer patients with ER-alpha positive tumors progress on antiestrogen therapy. The molecular mechanism(s) involved in antiestrogen-resistant phenotype of breast carcinoma is not completely understood," said N. Shoman and colleagues, University of...


Source: Women's Health Weekly (2005-04-28)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login